ARTMS

company

About

ARTMS is a developer of technology that transforms the production of diagnostic imaging isotopes.

  • 11 - 50

Details

Last Funding Type
Series A
Last Funding Money Raised
$19M
Industries
Health Care,Information Technology
Founded date
Jan 1, 2013
Number Of Employee
11 - 50
Operating Status
Active

ARTMS is a developer of technology that transforms the production of diagnostic imaging isotopes. Artms provides the QUANTM Irradiation SystemTM (QISTM), which enables decentralized, and local production of important medical isotopes including gallium-68 (68Ga), zirconium-89 (89Zr), technetium‐99m (99mTc) and copper-64 (64Cu).

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$19M
ARTMS has raised a total of $19M in funding over 2 rounds. Their latest funding was raised on May 20, 2020 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
May 20, 2020 Series A $19M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
ARTMS is funded by 1 investors. Global health sciences venture fund are the most recent investors.
Investor Name Lead Investor Funding Round
Global health sciences venture fund Series A